Swallowing improvement after levodopa treatment in idiopathic Parkinson's disease: lack of evidence
- PMID: 23231973
- DOI: 10.1016/j.parkreldis.2012.11.017
Swallowing improvement after levodopa treatment in idiopathic Parkinson's disease: lack of evidence
Abstract
Swallowing impairment is the main cause of pulmonary infection and death in Parkinson's disease (PD). To date, there is no established effective treatment to restore swallowing function among these subjects. Levodopa is considered the gold standard treatment for motor symptoms in PD but its efficacy in improving oropharyngeal and esophageal dysphagia remains controversial.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Comment in
-
Levodopa treatment in Parkinson's disease: how does it affect dysphagia management?Parkinsonism Relat Disord. 2014 Mar;20(3):340-1. doi: 10.1016/j.parkreldis.2013.09.013. Epub 2013 Sep 20. Parkinsonism Relat Disord. 2014. PMID: 24094704 No abstract available.
-
Swallowing improvement after levodopa treatment in idiopathic Parkinson's disease: lack of evidence. Authors' reply.Parkinsonism Relat Disord. 2014 Mar;20(3):342. doi: 10.1016/j.parkreldis.2013.10.028. Epub 2013 Nov 18. Parkinsonism Relat Disord. 2014. PMID: 24300049 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
